Civic Data
FDA RecallsUSDA RecallsAbout

FDA Recalls

  • Food recalls
  • Drug recalls
  • Device recalls

USDA Recalls

  • All USDA recalls
  • Poultry recalls
  • Meat recalls
  • Egg recalls

About

  • About us
  • FDA guides
  • USDA guides
  • Data sources
  • Privacy policy

Data

  • OpenFDA API
  • USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

  1. FDA Recalls
  2. ›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification
AllClass IClass IIClass III
Status
AllOngoingCompletedTerminated
Date
All timePast 30 daysPast 12 months

Showing 16421–16440 of 17,860 recalls

Class IIOngoing

Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

PEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Ketoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Atipamezole 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Vitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IITerminated

Mic Ultra-Sulfur Free 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200

Main Street Family Pharmacy, LLC

The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.

May 28, 2013 · DrugView details →
Class IITerminated

Depo-Testadiiol, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200

Main Street Family Pharmacy, LLC

The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.

May 28, 2013 · DrugView details →
← PreviousPage 822 of 893Next →